tiprankstipranks
Advertisement
Advertisement

Premier Anti-Aging Beats Profit Forecasts Despite Weaker Sales and Keeps Full-Year Outlook

Story Highlights
  • Premier Anti-Aging missed interim sales targets but significantly beat profit forecasts thanks to lower advertising spend and cost-structure reforms.
  • Despite a tough competitive landscape and soft demand, the company will increase marketing investments yet maintain its full-year earnings outlook unchanged.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Premier Anti-Aging Beats Profit Forecasts Despite Weaker Sales and Keeps Full-Year Outlook

Meet Samuel – Your Personal Investing Prophet

Premier Anti-Aging Co., Ltd. ( (JP:4934) ) has shared an update.

Premier Anti-Aging reported interim consolidated net sales of ¥7.34 billion for the six months to Jan. 31, 2026, falling short of its ¥8.0 billion forecast as mail order anti-aging sales and the Venex recovery business underperformed amid slow new customer acquisition and intensifying online competition. However, operating profit surged to ¥626 million versus a ¥150 million forecast, and profit attributable to owners of parent jumped to ¥445 million, as lower-than-planned advertising spend in the anti-aging segment and deeper cost-cutting in personnel and outsourcing costs more than offset weaker revenue.

Management signaled a challenging environment ahead for mail order and wholesale sales, particularly in the Chinese market, and for the Venex recovery business facing stronger e-commerce rivals, but chose to keep full-year earnings forecasts unchanged. From the third quarter, the company plans to ramp up advertising and promotional investment across both anti-aging and recovery brands, including digital and influencer tie-ups, indicating a shift from short-term cost restraint toward growth-oriented marketing while monitoring whether competitive and macro pressures warrant future forecast revisions.

The most recent analyst rating on (JP:4934) stock is a Hold with a Yen854.00 price target. To see the full list of analyst forecasts on Premier Anti-Aging Co., Ltd. stock, see the JP:4934 Stock Forecast page.

More about Premier Anti-Aging Co., Ltd.

Premier Anti-Aging Co., Ltd., listed on the Tokyo Stock Exchange, operates in the beauty and wellness sector with a core focus on anti-aging products sold via mail order and wholesale channels. The company also runs a recovery and relaxation-related business through its subsidiary Venex Co., Ltd., and faces growing competition from e-commerce platforms in its key markets.

Average Trading Volume: 25,677

Technical Sentiment Signal: Sell

Current Market Cap: Yen6.49B

See more data about 4934 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1